Literature DB >> 27151915

Involvement of Microglial P2Y12 Signaling in Tongue Cancer Pain.

T Tamagawa1, M Shinoda2, K Honda3, A Furukawa1, K Kaji3, H Nagashima4, R Akasaka1, J Chen3, B J Sessle5, Y Yonehara1, K Iwata6.   

Abstract

To elucidate if microglial P2Y12 receptor (P2Y12R) mechanisms are involved in the trigeminal spinal subnucleus caudalis (Vc; also known as the medullary dorsal horn) in intraoral cancer pain, we developed a rat model of tongue cancer pain. Squamous cell carcinoma (SCC) cells were inoculated into the tongue of rats; sham control rats received the vehicle instead. Nociceptive behavior was measured as the head-withdrawal reflex threshold (HWRT) to mechanical or heat stimulation applied to the tongue under light anesthesia. On day 14 after the SCC inoculation, activated microglia and P2Y12R expression were examined immunohistochemically in the Vc. The HWRT was also studied in SCC-inoculated rats with successive intra-cisterna magna (i.c.m.) administration of specific P2Y12R antagonist (MRS2395) or intraperitoneal administration of minocycline, a microglial activation inhibitor. Tongue cancer was histologically verified in SCC-inoculated rats, within which the HWRT to mechanical stimulation of the tongue was significantly decreased, as compared with that of vehicle-inoculated rats, although the HWRT to heat stimulation was not. Microglia was strongly activated on day 14, and the administration of MRS2395 or minocycline reversed associated nocifensive behavior and microglial activation in SCC-inoculated rats for 14 d. The activity of Vc wide dynamic range nociceptive neurons was also recorded electrophysiologically in SCC-inoculated and sham rats. Background activity and noxious mechanically evoked responses of wide dynamic range neurons were significantly increased in SCC-inoculated rats versus sham rats, and background activity and mechanically evoked responses were significantly suppressed following i.c.m. administration of MRS2395 in SCC-inoculated rats as compared with sham. The present findings suggest that SCC inoculation that produces tongue cancer results in strong activation of microglia via P2Y12 signaling in the Vc, in association with increased excitability of Vc nociceptive neurons, reflecting central sensitization and resulting in tongue mechanical allodynia. © International & American Associations for Dental Research 2016.

Entities:  

Keywords:  chronic pain; medulla; microglia; purinergic receptor; squamous cell carcinoma; trigeminal nerve

Mesh:

Substances:

Year:  2016        PMID: 27151915     DOI: 10.1177/0022034516647713

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  13 in total

Review 1.  Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain.

Authors:  Gang Chen; Yu-Qiu Zhang; Yawar J Qadri; Charles N Serhan; Ru-Rong Ji
Journal:  Neuron       Date:  2018-12-19       Impact factor: 17.173

2.  Advances in Head and Neck Cancer Pain.

Authors:  Y Ye; D D Jensen; C T Viet; H L Pan; W M Campana; M Amit; M D Boada
Journal:  J Dent Res       Date:  2022-04-13       Impact factor: 8.924

Review 3.  P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.

Authors:  Lucas T Woods; Kevin Muñoz Forti; Vinit C Shanbhag; Jean M Camden; Gary A Weisman
Journal:  Biochem Pharmacol       Date:  2021-01-04       Impact factor: 5.858

4.  Single-nucleotide polymorphisms of the SLC17A9 and P2RY12 genes are significantly associated with phantom tooth pain.

Authors:  Moe Soeda; Seii Ohka; Daisuke Nishizawa; Junko Hasegawa; Kyoko Nakayama; Yuko Ebata; Ken-Ichi Fukuda; Kazutaka Ikeda
Journal:  Mol Pain       Date:  2022 Jan-Dec       Impact factor: 3.395

5.  EXPRESS: BDNF Signaling Contributes to Oral Cancer Pain in a Preclinical Orthotopic Rodent Model.

Authors:  Leah Chodroff; Michele Bendele; Vanessa Valenzuela; Michael Henry; Shivani Ruparel
Journal:  Mol Pain       Date:  2016-09-02       Impact factor: 3.395

6.  P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine.

Authors:  Feng Jing; Yixin Zhang; Ting Long; Wei He; Guangcheng Qin; Dunke Zhang; Lixue Chen; Jiying Zhou
Journal:  J Neuroinflammation       Date:  2019-11-13       Impact factor: 8.322

Review 7.  Acute and Chronic Pain from Facial Skin and Oral Mucosa: Unique Neurobiology and Challenging Treatment.

Authors:  Man-Kyo Chung; Sheng Wang; Se-Lim Oh; Yu Shin Kim
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 8.  Glia and Orofacial Pain: Progress and Future Directions.

Authors:  Yi Ye; Elizabeth Salvo; Marcela Romero-Reyes; Simon Akerman; Emi Shimizu; Yoshifumi Kobayashi; Benoit Michot; Jennifer Gibbs
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

9.  Treatment of chronic neuropathic pain: purine receptor modulation.

Authors:  Kenneth A Jacobson; Luigino Antonio Giancotti; Filomena Lauro; Fatma Mufti; Daniela Salvemini
Journal:  Pain       Date:  2020-07       Impact factor: 7.926

Review 10.  P2Y12 Receptors in Tumorigenesis and Metastasis.

Authors:  Patrizia Ballerini; Melania Dovizio; Annalisa Bruno; Stefania Tacconelli; Paola Patrignani
Journal:  Front Pharmacol       Date:  2018-02-02       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.